Pharmacological targets in the ubiquitin system offer new ways of treating cancer, neurodegenerative disorders and infectious diseases.

Expert reviews in molecular medicine

Volumn 13, Issue , 2011, Pages

  Edelmann, Mariola J ^a   Nicholson, Benjamin ^b   Kessler, Benedikt M ^b  

^a MISSISSIPPI STATE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTEASOME; UBIQUITIN; UBIQUITIN PROTEIN LIGASE; UBIQUITIN THIOLESTERASE; USP7 PROTEIN, HUMAN;

ANIMAL; COMMUNICABLE DISEASE; DEGENERATIVE DISEASE; DRUG DESIGN; HUMAN; METABOLISM; MOLECULARLY TARGETED THERAPY; NEOPLASM; REVIEW;

ANIMALS; COMMUNICABLE DISEASES; DRUG DESIGN; HUMANS; MOLECULAR TARGETED THERAPY; NEOPLASMS; NEURODEGENERATIVE DISEASES; PROTEASOME ENDOPEPTIDASE COMPLEX; UBIQUITIN; UBIQUITIN THIOLESTERASE; UBIQUITIN-PROTEIN LIGASES;

MLCS; MLOWN;

EID: 84857085837     PISSN: None     EISSN: 14623994     Source Type: Journal    
DOI: 10.1017/s1462399411002031     Document Type: Review

References (0)